Case Report: A PD-L1-Positive Patient With Pleomorphic Rhabdomyosarcoma Achieving an Impressive Response to Immunotherapy

There is currently a lack of effective systemic treatment for patients with advanced pleomorphic rhabdomyosarcoma (PRMS). Although programmed death protein 1 (PD-1) inhibitors have shown efficacy in various solid tumors, their effects on PRMS have not been well established. Here, we present a case o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiayong, Liu, Peijie, Gong, Fuyu, Tian, Youhui, Zhao, Xiaochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968025/
https://www.ncbi.nlm.nih.gov/pubmed/35371041
http://dx.doi.org/10.3389/fimmu.2022.815598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968025/
https://www.ncbi.nlm.nih.gov/pubmed/35371041
http://dx.doi.org/10.3389/fimmu.2022.815598

Ejemplares similares